UN Secretary-General’s High-level Panel: a bold vision for improving access to essential medicines, or a “deep disappointment”?

The UN Secretary General’s High-level Panel on Access to Medicines published its final report on 14 September 2016. It took just two days for the US State Department to dismiss the report in a strongly-worded rebuke. The Panel’s recommendations cover a wide area, including countries’ use of the flexibilities contained in TRIPS [the World Trade … Continue reading UN Secretary-General’s High-level Panel: a bold vision for improving access to essential medicines, or a “deep disappointment”?